Pramipexole Dihydrochloride Tablets, 0.125 mg, 90-count tablets per bottle, Rx only, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ 08540, NDC 0781-5248-92
Published September 26, 2012 · Recall initiated: September 12, 2012
Summary
FDA records drug Class III recall D-1678-2012, published September 26, 2012 and initiated September 12, 2012. Recalling firm: Sandoz Incorporated; Status: Terminated; Reported quantity: 41,761bottles.; Lot: Lot numbers: KW10J511, KW10J512, KW10J513, KW10J514, KW10J515, BJ3167, BJ3172, BJ3177, BJ3179, BJ3188, BJ3182. Exp. 09/12. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Sandoz Incorporated
- Distributor
- Nationwide
- Lot
- Lot numbers: KW10J511, KW10J512, KW10J513, KW10J514, KW10J515, BJ3167, BJ3172, BJ3177, BJ3179, BJ3188, BJ3182. Exp. 09/12
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATriamterene and Hydrochlorothiazide Tablets, USP, 75 mg/50 mg, 500-count bottles, Rx only, Manufactured byApril 25, 2018
- FDAAmitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-countJuly 12, 2017
- FDANadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJJanuary 4, 2017
- FDAFluoxetine Capsules USP, 20 mg, 100 count bottle, Rx Only, 100 Capsules, Sandoz Inc Princeton, NJ 08540 NDCDecember 17, 2014
- FDAPramipexole Dihydrochloride Tablets, 0.25 mg, 90-count tablets per bottle, Rx only, Manufactured in India bySeptember 26, 2012
- FDACarboplatin Injection, 10 mg/mL, 45 mL Multi-Dose Vial, Rx only, antineoplastic/cytotoxic agent; ManufacturedSeptember 26, 2012
Questions about this recall
Was Pramipexole Dihydrochloride Tablets, 0.125 mg, 90-count tablets per bottle, Rx only, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ 08540, NDC 0781-5248-92 recalled?
Yes. FDA published recall D-1678-2012 on September 26, 2012. Reported hazard: Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter